Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar 5;125(10):1526-31.
doi: 10.1182/blood-2014-10-559211. Epub 2015 Jan 8.

The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura

Wendy Lim  1 , Sara K Vesely  2 , James N George  2
Affiliations
Review

The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura

Wendy Lim et al. Blood. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Literature search data. *One article included 2 case series: one case series of patients receiving initial treatment with rituximab and another case series of asymptomatic patients receiving rituximab prophylaxis.
See this image and copyright information in PMC

Comment in

References

    1. Rock GA, Shumak KH, Buskard NA, et al. Canadian Apheresis Study Group. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med. 1991;325(6):393–397. - PubMed
    1. Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med. 1998;339(22):1578–1584. - PubMed
    1. Tsai HM, Lian EC-Y. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998;339(22):1585–1594. - PMC - PubMed
    1. Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med. 1991;325(6):398–403. - PubMed
    1. Chemnitz J, Draube A, Scheid C, et al. Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab. Am J Hematol. 2002;71(2):105–108. - PubMed

Supplementary concepts